The glucagon component particularly appears to prevent the metabolic adaptation that often limits weight loss success
For understanding the mechanism and how it relates to dosing, see mechanism of action
Myopathy , by which we refer to any muscular sign or symptom, are common in lcFAOD patients
Turning to Reddit to interpret their labs (just look at r/AskDocs, where 700k+ people ask personal medical questions every day)
Retatrutide (LY3437943) is a single peptide engineered to agonise three incretin-family receptors at once: the glucagon-like peptide-1 receptor (GLP-1R), the glucose-dependent insulinotropic polypeptide receptor (GIPR), and the glucagon receptor (GCGR) 26
So my guess is, and a lot of policymakers have said the same thing, and economists, that you will not see a drop in the average wholesale price of the Humira nor a significant difference in the biosimilars when theyre introduced in the marketplace